regenxbio.com - Bathi operasional sadurunge amortisasi RGNX
REGENXBIO Inc. (RGNX) is a gene therapy leader featuring a unique NAV platform and a robust patent portfolio. The firm's environmental footprint remains minimal due to strict chemical controls. The GURU.Markets platform provides this chart, where absolute EBITDA dynamics show that the current level is around 0.00. However, financial stability depends on one-time partner payments until the full-scale launch of its own products.
%20Bathi%20operasional%20EBITDA&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_RGNX_-_REGENXBIO-Inc._-_Operating-profit-EBITDA "REGENXBIO Inc - Bathi sadurunge mbayar bunga, pajak, lan amortisasi RGNX (periode 23.11.2025 - 13.11.2026) | 👁️GURU.Markets👁️")
REGENXBIO - rincian analitis lan metrik utama (RGNX)
- rega saham lan prakiraan rega para ahli:
- rincian nilai pasar emiten:
- indikator nilai aset resik miturut neraca:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal REGENXBIO Inc.|RGNX - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal REGENXBIO Inc|RGNX - Gunggung utang perusahaan|Utang-utang marang aset resik REGENXBIO|RGNX - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan REGENXBIO|Indikator likuiditas cepet regenxbio.com
- indikator pendapatan resik lan kelipatan nilai:
RGNX - Penghasilan resik|Prakiraan bathi perusahaan REGENXBIO Inc.|RGNX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi regenxbio.com|RGNX - Pangali PEG|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan REGENXBIO|RGNX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan REGENXBIO|RGNX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan regenxbio.com|RGNX - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep REGENXBIO Inc.
Ringkesan analitik perusahaan:RGNX REGENXBIO Corp
For REGENXBIO Inc. (RGNX), whose gene therapy developments for blindness are entering the commercialization stage, the company's total operating profit reflects the actual cash flow from the core business before depreciation and interest. This indicator measures the efficiency of the operating cycle, allowing investors to assess the issuer's ability to cover expenses and service debt amid tight monetary policy.
Pesaing REGENXBIO Inc. (RGNX)
TEM: Bathi operasional sadurunge amortisasi|QGEN: Bathi operasional sadurunge ngurangi amortisasi|IONS (ionispharma.com) - Bathi operasional sadurunge amortisasi|RGEN: Bathi operasional EBITDA|RNA (Avidity Biosciences Inc) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|GeneDx Corp (WGS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|BEAM - Bathi sadurunge bunga, pajak, lan amortisasi|Sarepta - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TWST|10x Genomics Corp - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Intellia Corp NTLA|Stoke Therapeutics (STOK) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi BLFS|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Maze Therapeutics, Inc. (MAZE)|Bathi operasional sadurunge ngurangi amortisasi SION (Sionna Pharma)|Pendapatan operasional sadurunge ngurangi amortisasi Prime Medicine Bio|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Taysha Gene Therapies TSHA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi QURE|MeiraGTx - Bathi operasional EBITDA|Bathi operasional sadurunge potongan amortisasi Solid Biosciences Inc (SLDB)|Ocugen Corp (OCGN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi PACB|Bathi operasional sadurunge ngurangi amortisasi BNTC|Bathi operasional sadurunge amortisasi DSGN (designtx.com)|Bathi operasional EBITDA RCKT|4DMT - Bathi operasional sadurunge amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexeo Therapeutics, Inc. LXEO|KRRO: Bathi operasional sadurunge amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|SLN - Bathi operasional EBITDA|proqr.com (PRQR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Codexis - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Nautilus Biotechnology Inc NAUT|Bathi operasional EBITDA MGX|precisionbiosciences.com (DTIL) - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA GBIO (Generation Bio)|Boundless Bio Inc. (BOLD) - Bathi sadurunge bunga, pajak, lan amortisasi|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IMNN (Imunon, Inc.) - Bathi operasional sadurunge amortisasi|PHIO (phiopharma.com) - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge amortisasi MBIO|RNAZ (TransCode Therapeutics Inc.) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BNGO|Bathi operasional EBITDA APDN|Pendapatan operasional sadurunge ngurangi amortisasi bluebird bio, Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|omegatherapeutics.com (OMGA) - Bathi sadurunge bunga, pajak, lan amortisasi|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RGLS (Regulus Therapeutics, Inc.)|SYRS: Bathi operasional EBITDA|TBIO - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|Bathi operasional sadurunge amortisasi UBX (unitybiotechnology.com)
